NEUROPACE, INC. Increase (Decrease) in Derivative Liabilities
NEUROPACE, INC. (NPCE) reported Increase (Decrease) in Derivative Liabilities of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2022-03-10
- NEUROPACE, INC. increase (decrease) in derivative liabilities for the quarter ending 2021-12-31 was $0.00.
- NEUROPACE, INC. increase (decrease) in derivative liabilities for the quarter ending 2021-09-30 was $0.00.
- NEUROPACE, INC. increase (decrease) in derivative liabilities for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- NEUROPACE, INC. increase (decrease) in derivative liabilities for the quarter ending 2021-03-31 was $0.00.
- NEUROPACE, INC. increase (decrease) in derivative liabilities for fiscal 2021 was $0.00.
- NEUROPACE, INC. increase (decrease) in derivative liabilities for fiscal 2020 was -$149.00K.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $0.00 derived: sum of 2 quarters · filed 2022-03-10 | $0.00 derived: sum of 3 quarters · filed 2022-03-10 | $0.00 10-K · filed 2022-03-10 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 4 quarters · filed 2022-03-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | $0.00 derived: sum of 3 quarters · filed 2022-03-10 | $0.00 derived: sum of 4 quarters · filed 2022-03-10 |
| 2021-03-31 | $0.00 10-Q · filed 2021-06-03 | $0.00 derived: sum of 2 quarters · filed 2022-03-10 | $0.00 derived: sum of 3 quarters · filed 2022-03-10 | $1.56M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $0.00 derived: sum of 2 quarters · filed 2022-03-10 | $1.56M derived: sum of 3 quarters · filed 2022-03-10 | -$149.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.56M derived: sum of 2 quarters · filed 2021-11-10 | -$149.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$149.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$1.71M 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |